Expert reviewers for Orphanet in 2015


PDF
List Docs
PDF Expert reviewers for Orphanet in 2015

Expert reviewers for Orphanet in 2015 www orpha net METHODOLOGY This document provides the list of Orphanet Expert reviewers having contributed updating the scientific information contained in the Orphanet database of rare diseases in 2015

PDF Expert reviewers for Orphanet in 2019

List of expert reviewers for Orphanet in 2019 Expert\'s name Disease name ORPHA code Dr ABRUZZO Michael Abruzzo-Erickson syndrome 921 Pr AHMED Faisal 46XX testicular disorder of sex development 393 46XX ovotesticular disorder of sex development 2138 Dr ANGLES-CANO Eduardo Congenital plasminogen activator inhibitor type 1 deficiency 465 Dr

PDF Expert reviewers for Orphanet in 2020

Orphanet Report Series - Expert Reviewers for Orphanet in 2020 http://www orpha net/orphacom/cahiers/docs/GB/Expert_reviewers_2020 pdf 5 Expert ERN Affiliation Disease name ORPHAcode Usher syndrome type 2 ORPHA:231178 Usher syndrome type 1 ORPHA:231169 Usher syndrome ORPHA:886 Pr BLAU Nenad Maternal phenylketonuria ORPHA:2209

  • What are Orphanet reports?

    Orphanet reports are a serie of texts covering topics relevant to all rare diseases. New reports are regularly put online and some of these texts are periodically updated. This document has been translated into Czech (January 2021) This document has been translated into Russian January 2022 - n°1

  • Are Orphan Medicinal Products a viable option for patients with rare diseases?

    The number of market approvals of orphan medicinal products (OMPs) has been increasing steadily in the last 3 decades. While OMPs can offer a unique chance for patients suffering from rare diseases, they are usually very expensive.

  • Is the Orphanet website user friendly?

    The Orphanet website was reworked in March 2017 to improve its user friendliness. Despite this total make over, around 15% of the collected responses showed that the website in not user friendly enough.

  • Will orphan win any awards?

    Orphan won't win any awards (despite Fuhrman's impressive performance) and might well get passed over by many based on the trailer, all of which is too bad because this is one stray that movie audiences would do well to adopt. 201 out of 256 found this helpful. Was this review helpful? Sign in to vote. It's a Hard Knock Life...

Share on Facebook Share on Whatsapp











Choose PDF
More..











expert si marketing (h/f) alternance – castres (81) - Gestion De Données Expert technique Java / JEE - Espèces En Voie De Disparition EXPERT TECHNIQUE RESEAU ET SECURITE H/F Expert Tepee - France Expert Virtualisation et poste de travail (H/F) - Offre d`emploi Expert Working Group “Bid Ladder” - Anciens Et Réunions Expert(e) en Qualité/accréditation en Santé Sénégal - Santé Et Remise En Forme Expert-Comptable - France

PDFprof.com Search Engine
Images may be subject to copyright Report CopyRight Claim

PDF) Clinical Practice Guidelines for Rare Diseases: The Orphanet

PDF) Clinical Practice Guidelines for Rare Diseases: The Orphanet


Orphanet: Cornelia de Lange syndrome

Orphanet: Cornelia de Lange syndrome


PDF) Representation of Rare Diseases in Health Information Systems

PDF) Representation of Rare Diseases in Health Information Systems


report on rare disease research  its determinants in  - Orphanet

report on rare disease research its determinants in - Orphanet


Estimating cumulative point prevalence of rare diseases: analysis

Estimating cumulative point prevalence of rare diseases: analysis


Clinical Practice Guidelines for Rare Diseases: The Orphanet Database

Clinical Practice Guidelines for Rare Diseases: The Orphanet Database


A guide to writing systematic reviews of rare disease treatments

A guide to writing systematic reviews of rare disease treatments


Clinical Practice Guidelines for Rare Diseases: The Orphanet Database

Clinical Practice Guidelines for Rare Diseases: The Orphanet Database


Estimating cumulative point prevalence of rare diseases: analysis

Estimating cumulative point prevalence of rare diseases: analysis


Orphanet: Duchenne muscular dystrophy

Orphanet: Duchenne muscular dystrophy


To what degree are orphan drugs patient-centered? A review of the

To what degree are orphan drugs patient-centered? A review of the


Clinical Practice Guidelines for Rare Diseases: The Orphanet Database

Clinical Practice Guidelines for Rare Diseases: The Orphanet Database


Estimating cumulative point prevalence of rare diseases: analysis

Estimating cumulative point prevalence of rare diseases: analysis


Challenges in Research and Health Technology Assessment of Rare

Challenges in Research and Health Technology Assessment of Rare


Impact of biobanks on research outcomes in rare diseases: a

Impact of biobanks on research outcomes in rare diseases: a


Access and Unmet Needs of Orphan Drugs in 194 Countries and 6

Access and Unmet Needs of Orphan Drugs in 194 Countries and 6


Clinical Practice Guidelines for Rare Diseases: The Orphanet Database

Clinical Practice Guidelines for Rare Diseases: The Orphanet Database


Treatment of Satoyoshi syndrome: a systematic review

Treatment of Satoyoshi syndrome: a systematic review


Full text] Ethical Questions Linked to Rare Diseases and Orphan

Full text] Ethical Questions Linked to Rare Diseases and Orphan


Estimating cumulative point prevalence of rare diseases: analysis

Estimating cumulative point prevalence of rare diseases: analysis


Diagnosis support systems for rare diseases: a scoping review

Diagnosis support systems for rare diseases: a scoping review


Estimating cumulative point prevalence of rare diseases: analysis

Estimating cumulative point prevalence of rare diseases: analysis


Cutis marmorata telangiectatica congenita: a literature review

Cutis marmorata telangiectatica congenita: a literature review


Defining Patient Engagement in Research: Results of a Systematic

Defining Patient Engagement in Research: Results of a Systematic


Top PDF Characteristics of drugs for ultra-rare diseases versus

Top PDF Characteristics of drugs for ultra-rare diseases versus


Searching for rare diseases in PubMed: a blind comparison of

Searching for rare diseases in PubMed: a blind comparison of


9th European Conference on Rare Diseases \u0026 Orphan Products (ECRD

9th European Conference on Rare Diseases \u0026 Orphan Products (ECRD


The existing scenario of haemophilia care in Canada and China - A

The existing scenario of haemophilia care in Canada and China - A


Frontiers

Frontiers


Electronic health records for the diagnosis of rare diseases

Electronic health records for the diagnosis of rare diseases


A guide to writing systematic reviews of rare disease treatments

A guide to writing systematic reviews of rare disease treatments


Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare

Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare


9th European Conference on Rare Diseases \u0026 Orphan Products (ECRD

9th European Conference on Rare Diseases \u0026 Orphan Products (ECRD


OECD iLibrary

OECD iLibrary

Politique de confidentialité -Privacy policy